JP2017505626A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017505626A5 JP2017505626A5 JP2016549495A JP2016549495A JP2017505626A5 JP 2017505626 A5 JP2017505626 A5 JP 2017505626A5 JP 2016549495 A JP2016549495 A JP 2016549495A JP 2016549495 A JP2016549495 A JP 2016549495A JP 2017505626 A5 JP2017505626 A5 JP 2017505626A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- subject
- expression vector
- cells
- lentiviral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013604 expression vector Substances 0.000 claims description 15
- 108091005886 Hemoglobin subunit gamma Proteins 0.000 claims description 10
- 241000713666 Lentivirus Species 0.000 claims description 10
- 239000013598 vector Substances 0.000 claims description 10
- 210000004027 cell Anatomy 0.000 claims description 9
- 208000018020 Sickle cell-beta-thalassemia disease syndrome Diseases 0.000 claims description 7
- 206010043391 Thalassaemia beta Diseases 0.000 claims description 7
- 208000007056 sickle cell anemia Diseases 0.000 claims description 7
- 230000003612 virological effect Effects 0.000 claims description 6
- 108700028146 Genetic Enhancer Elements Proteins 0.000 claims description 5
- 102100021519 Hemoglobin subunit beta Human genes 0.000 claims description 5
- 108091005904 Hemoglobin subunit beta Proteins 0.000 claims description 5
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 5
- 238000012217 deletion Methods 0.000 claims description 5
- 230000037430 deletion Effects 0.000 claims description 5
- 230000000925 erythroid effect Effects 0.000 claims description 5
- 239000012212 insulator Substances 0.000 claims description 5
- 208000024891 symptom Diseases 0.000 claims description 5
- 238000002054 transplantation Methods 0.000 claims description 5
- 108010044495 Fetal Hemoglobin Proteins 0.000 claims description 4
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 4
- 210000003995 blood forming stem cell Anatomy 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 230000006490 viral transcription Effects 0.000 claims description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
- 108010054147 Hemoglobins Proteins 0.000 claims description 2
- 102000001554 Hemoglobins Human genes 0.000 claims description 2
- 210000001185 bone marrow Anatomy 0.000 claims description 2
- 230000003750 conditioning effect Effects 0.000 claims description 2
- 210000003743 erythrocyte Anatomy 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- 108060003196 globin Proteins 0.000 claims 1
- 238000002513 implantation Methods 0.000 claims 1
- 238000001890 transfection Methods 0.000 claims 1
- 238000000034 method Methods 0.000 description 9
- 101100455521 Arabidopsis thaliana LSD1 gene Proteins 0.000 description 2
- 101150079814 CHS4 gene Proteins 0.000 description 2
- 101100203325 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SKT5 gene Proteins 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461933788P | 2014-01-30 | 2014-01-30 | |
| US61/933,788 | 2014-01-30 | ||
| PCT/US2015/013960 WO2015117027A1 (en) | 2014-01-30 | 2015-01-30 | An improved fetal hemoglobin for genetic correction of sickle cell disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017505626A JP2017505626A (ja) | 2017-02-23 |
| JP2017505626A5 true JP2017505626A5 (https=) | 2018-03-08 |
| JP6509884B2 JP6509884B2 (ja) | 2019-05-08 |
Family
ID=53757790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016549495A Active JP6509884B2 (ja) | 2014-01-30 | 2015-01-30 | 鎌状赤血球病の遺伝子的是正のための改善された胎児ヘモグロビン |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10072067B2 (https=) |
| EP (1) | EP3099334B1 (https=) |
| JP (1) | JP6509884B2 (https=) |
| CN (1) | CN106456802B (https=) |
| AU (2) | AU2015210775B2 (https=) |
| CA (1) | CA2938419C (https=) |
| ES (1) | ES2747817T3 (https=) |
| WO (1) | WO2015117027A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6509884B2 (ja) | 2014-01-30 | 2019-05-08 | チルドレンズ ホスピタル メディカル センター | 鎌状赤血球病の遺伝子的是正のための改善された胎児ヘモグロビン |
| EP3620521B1 (en) * | 2014-09-04 | 2024-05-29 | Memorial Sloan-Kettering Cancer Center | Globin gene therapy for treating hemoglobinopathies |
| EP3368052B1 (en) | 2015-10-27 | 2021-12-08 | Children's Hospital Medical Center | Use of mapk inhibitors to reduce loss of hematopoietic stem cells during ex vivo culture and genetic manipulation |
| CN106497976A (zh) * | 2016-10-31 | 2017-03-15 | 广东铱科基因科技有限公司 | 一种用于矫正重症β‑地中海贫血患者自体造血干细胞的HBB基因试剂盒 |
| CN111164211B (zh) * | 2017-07-18 | 2024-08-02 | 杰特贝林基因治疗股份有限公司 | 用于治疗β-血红蛋白病的组合物和方法 |
| CN111093715A (zh) | 2017-09-18 | 2020-05-01 | 儿童医院医疗中心 | 强绝缘子和其在基因递送中的用途 |
| CN109722414A (zh) * | 2017-10-27 | 2019-05-07 | 博雅辑因（北京）生物科技有限公司 | 一种高效制备成熟红细胞的方法以及用于制备成熟红细胞的培养基 |
| JP7470119B2 (ja) * | 2018-08-24 | 2024-04-17 | シーエスエル ベーリング ジーン セラピー インコーポレイテッド | 無血清培地におけるベクター産生 |
| US20210380946A1 (en) * | 2018-11-01 | 2021-12-09 | Children's Hospital Medical Center | Reduced intensity conditioning with melphalan |
| WO2020209934A1 (en) | 2019-04-11 | 2020-10-15 | Massachusetts Institute Of Technology | Novel chimeric antigen receptors and libraries |
| WO2020214676A1 (en) * | 2019-04-15 | 2020-10-22 | Children's Hospital Medical Center | Viral vector manufacturing methods |
| JP7658584B2 (ja) | 2019-05-23 | 2025-04-08 | マサチューセッツ インスティテュート オブ テクノロジー | リガンドの発見およびレトロウイルス表面ディスプレーを介した遺伝子送達 |
| WO2021010937A1 (en) | 2019-07-17 | 2021-01-21 | Emmaus Medical, Inc. | Methods and compositions for the treatment of sickle cell diseases and thalassemia |
| AU2022227021A1 (en) | 2021-02-26 | 2023-09-21 | Kelonia Therapeutics, Inc. | Lymphocyte targeted lentiviral vectors |
| WO2024050450A1 (en) | 2022-08-31 | 2024-03-07 | Gigamune, Inc. | Engineered enveloped vectors and methods of use thereof |
| AU2024353718A1 (en) | 2023-09-25 | 2026-04-09 | Kelonia Therapeutics, Inc. | Compositions for treating cancer |
| AU2024353243A1 (en) | 2023-09-25 | 2026-04-09 | Kelonia Therapeutics, Inc. | Antigen binding polypeptides |
| WO2025151744A1 (en) * | 2024-01-10 | 2025-07-17 | University Of Tennessee Research Foundation | Improved globin and other lentiviral vectors for gene therapy |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7744491A (en) * | 1990-04-16 | 1991-11-11 | Strohtech, Inc. | Expression of recombinant hemoglobin in yeast |
| US6172039B1 (en) | 1990-04-16 | 2001-01-09 | Apex Bioscience, Inc. | Expression of recombinant hemoglobin and hemoglobin variants in yeast |
| CA2246005A1 (en) | 1998-10-01 | 2000-04-01 | Hsc Research And Development Limited Partnership | Hybrid genes for gene therapy in erythroid cells |
| NZ519034A (en) * | 1999-12-14 | 2005-02-25 | Novartis Ag | Bovine immunodeficiency virus (BIV) based vectors |
| WO2003002155A1 (en) * | 2001-06-29 | 2003-01-09 | Sloan Kettering Institute For Cancer Research | Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies |
| US20050014166A1 (en) | 2002-11-22 | 2005-01-20 | Institut Clayton De La Recherche | Compositions and systems for the regulation of genes |
| WO2004083383A2 (en) | 2003-03-14 | 2004-09-30 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Globin variant gene methods and compositions |
| WO2005030999A1 (en) | 2003-09-25 | 2005-04-07 | Dana-Farber Cancer Institute, Inc | Methods to detect lineage-specific cells |
| US7276340B1 (en) | 2004-09-22 | 2007-10-02 | University Of Central Florida Research Foundation, Inc. | Age determination from biological stains using messenger RNA profiling analysis |
| US20090156534A1 (en) * | 2007-09-13 | 2009-06-18 | Memorial Sloan-Kettering Cancer Center | Globin lentiviral vectors for treatment of disease |
| EP2424987B1 (en) | 2009-05-01 | 2017-11-15 | CuRNA, Inc. | Treatment of hemoglobin (hbf/hbg) related diseases by inhibition of natural antisense transcript to hbf/hbg |
| US20110294114A1 (en) | 2009-12-04 | 2011-12-01 | Cincinnati Children's Hospital Medical Center | Optimization of determinants for successful genetic correction of diseases, mediated by hematopoietic stem cells |
| KR101931403B1 (ko) * | 2011-09-23 | 2018-12-21 | 블루버드 바이오, 인코포레이티드. | 개선된 유전자 치료 방법 |
| JP6509884B2 (ja) | 2014-01-30 | 2019-05-08 | チルドレンズ ホスピタル メディカル センター | 鎌状赤血球病の遺伝子的是正のための改善された胎児ヘモグロビン |
-
2015
- 2015-01-30 JP JP2016549495A patent/JP6509884B2/ja active Active
- 2015-01-30 US US15/115,530 patent/US10072067B2/en active Active
- 2015-01-30 CA CA2938419A patent/CA2938419C/en active Active
- 2015-01-30 CN CN201580018389.5A patent/CN106456802B/zh active Active
- 2015-01-30 ES ES15744021T patent/ES2747817T3/es active Active
- 2015-01-30 AU AU2015210775A patent/AU2015210775B2/en active Active
- 2015-01-30 WO PCT/US2015/013960 patent/WO2015117027A1/en not_active Ceased
- 2015-01-30 EP EP15744021.5A patent/EP3099334B1/en active Active
-
2018
- 2018-06-01 US US15/995,675 patent/US11345740B2/en active Active
-
2020
- 2020-09-30 AU AU2020244473A patent/AU2020244473B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017505626A5 (https=) | ||
| US11667890B2 (en) | Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion | |
| AU2018311504B2 (en) | Cellular models of and therapies for ocular diseases | |
| Arumugam et al. | Improved human β-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator element | |
| PH12021552638A1 (en) | Compositions useful for treatment of pompe disease | |
| Li et al. | In vivo base editing by a single iv vector injection for treatment of hemoglobinopathies | |
| Bueren et al. | Advances in the gene therapy of monogenic blood cell diseases | |
| JP7842149B2 (ja) | Ｐｋｌｒの遺伝子発現増強のための組成物および方法 | |
| JP2019533434A5 (https=) | ||
| EP4368703A1 (en) | Mesenchymal stem cell having oxidative stress resistance, preparation method therefor, and use thereof | |
| CN111235158A (zh) | 用于表达重组人β-珠蛋白的病毒载体及其应用 | |
| CN113316637A (zh) | 依靠人工反式激活物的选择 | |
| AU2018345536B2 (en) | Treating diabetes with genetically modified beta cells | |
| US20230365996A1 (en) | Replacement of rag1 for use in therapy | |
| Burnight et al. | Gene therapy using stem cells | |
| Petit et al. | Gene transfer of two entry inhibitors protects CD4+ T cell from HIV-1 infection in humanized mice | |
| JP2020517289A5 (https=) | ||
| HRP20240806T1 (hr) | Metode liječenja reumatoidnog artritisa pomoću rna-vođenog genoma uređivanja hla gena | |
| ES2864731T3 (es) | Terapias a base de la telomerasa transcriptasa inversa | |
| CN105018524B (zh) | 一种细胞寿命延长及成血管能力增强的人干细胞的制备方法及其试剂盒 | |
| US12440579B2 (en) | Optimised RAG1 deficient gene therapy | |
| CN116635523A (zh) | 用于疗法中的rag1的替代物 | |
| Geller et al. | In vitro analysis of promoter activity in Müller cells | |
| US20240425851A1 (en) | Polynucleotides useful for correcting mutations in the rag1 gene | |
| RU2023119872A (ru) | Генная терапия пациентов с анемией фанкони |